- 2026-03-18 13:28Anti-hepatic fibrosis agent 2 2380421-60-1
- 2026-03-18 13:28Anivamersen sodium 959716-31-5
- 2026-03-18 13:28Anivamersen 959716-29-1
- 2026-03-18 13:28Anhydroleucovorin 7444-29-3
- 2026-03-18 13:28Angiogenesis inhibitor 4 417719-77-8
- 2026-03-18 13:28And1-IN-1 2451028-69-4
- 2026-03-18 13:28ANAT inhibitor-2 1048244-34-3
- 2026-03-18 13:27ANAT inhibitor-1 331751-78-1
- 2026-03-18 13:27Analgesic agent-3 796115-75-8
- 2026-03-18 13:27Analgesic agent-1 2230243-92-0
- 2026-03-18 13:27Amylin (8-37) (human) (hIAPP (8-37)) 309244-90-4
- 2026-03-18 13:27Amylin (1-37) (human) (hIAPP (1-37)) 112938-42-8
- 2026-03-18 13:27AMT-NHS 2925268-86-4
- 2026-03-18 13:27AMPC 2254434-33-6
- 2026-03-18 13:27AMP-Deoxynojirimycin (AMP-DNM) 216758-20-2
- 2026-03-18 13:27Ammonium sulphate,≥99.0%,AR (ammonium sulfate,≥99.0%,AR) 7783-20-2
- 2026-03-18 13:27Amitriptyline N-β-D-glucuronide 112806-33-4
- 2026-03-18 13:27Aluminum Glycinate (dihydroxyaluminum Aminoacetate; aluminum glycinate; Dihydroxyaluminum Aminoaceta
- 2026-03-18 13:27alpha 1-Antitrypsin (AAT) 9041-92-3
- 2026-03-18 13:26Allylic-SAM 875155-64-9
